Literature DB >> 27904303

Pharmacological Management and Prevention Of Exacerbations of Chronic Obstructive Pulmonary Disease in Hospitalized Patients.

Deepali Dixit, Mary Barna Bridgeman, Rani Patel Madduri, Samir T Kumar, Michael J Cawley.   

Abstract

Rapid-acting bronchodilators, systemic corticosteroids, and antibiotics are among the keys to managing exacerbations of chronic obstructive pulmonary disease. Preventing exacerbations should also be a component of therapy for the disease.

Entities:  

Keywords:  acute exacerbations; bronchodilators; chronic obstructive pulmonary disease (COPD); systemic steroids

Year:  2016        PMID： 27904303      PMCID： PMC5083078     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  48 in total

1.  Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Michael B Rothberg; Penelope S Pekow; Maureen Lahti; Oren Brody; Daniel J Skiest; Peter K Lindenauer
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

Review 2.  Infection in the pathogenesis and course of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Timothy F Murphy
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

Review 3.  Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Authors:  Philipp Schuetz; Beat Müller; Mirjam Christ-Crain; Daiana Stolz; Michael Tamm; Lila Bouadma; Charles E Luyt; Michel Wolff; Jean Chastre; Florence Tubach; Kristina B Kristoffersen; Olaf Burkhardt; Tobias Welte; Stefan Schroeder; Vandack Nobre; Long Wei; Neera Bhatnagar; Heiner C Bucher; Matthias Briel
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

4.  Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Authors:  Marc Decramer; Bartolome Celli; Steven Kesten; Theodore Lystig; Sunil Mehra; Donald P Tashkin
Journal:  Lancet       Date:  2009-08-27       Impact factor: 79.321

5.  Withdrawal of inhaled glucocorticoids and exacerbations of COPD.

Authors:  Helgo Magnussen; Bernd Disse; Roberto Rodriguez-Roisin; Anne Kirsten; Henrik Watz; Kay Tetzlaff; Lesley Towse; Helen Finnigan; Ronald Dahl; Marc Decramer; Pascal Chanez; Emiel F M Wouters; Peter M A Calverley
Journal:  N Engl J Med       Date:  2014-09-08       Impact factor: 91.245

6.  An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Authors:  Martijn A Spruit; Sally J Singh; Chris Garvey; Richard ZuWallack; Linda Nici; Carolyn Rochester; Kylie Hill; Anne E Holland; Suzanne C Lareau; William D-C Man; Fabio Pitta; Louise Sewell; Jonathan Raskin; Jean Bourbeau; Rebecca Crouch; Frits M E Franssen; Richard Casaburi; Jan H Vercoulen; Ioannis Vogiatzis; Rik Gosselink; Enrico M Clini; Tanja W Effing; François Maltais; Job van der Palen; Thierry Troosters; Daisy J A Janssen; Eileen Collins; Judith Garcia-Aymerich; Dina Brooks; Bonnie F Fahy; Milo A Puhan; Martine Hoogendoorn; Rachel Garrod; Annemie M W J Schols; Brian Carlin; Roberto Benzo; Paula Meek; Mike Morgan; Maureen P M H Rutten-van Mölken; Andrew L Ries; Barry Make; Roger S Goldstein; Claire A Dowson; Jan L Brozek; Claudio F Donner; Emiel F M Wouters
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

7.  Two different dosages of nebulized steroid versus parenteral steroid in the management of COPD exacerbations: a randomized control trial.

Authors:  Elif Yilmazel Ucar; Omer Araz; Mehmet Meral; Esin Sonkaya; Leyla Saglam; Hasan Kaynar; Ali Metin Gorguner; Metin Akgun
Journal:  Med Sci Monit       Date:  2014-03-28

8.  Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Ho Ii Yoon; Chang-Hoon Lee; Deog Kyeom Kim; Geun Min Park; Sang-Min Lee; Jae-Joon Yim; Jae-Yeol Kim; Jae Ho Lee; Choon-Taek Lee; Hee Soon Chung; Young Whan Kim; Sung Koo Han; Chul-Gyu Yoo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-07-10

9.  COPD surveillance--United States, 1999-2011.

Authors:  Earl S Ford; Janet B Croft; David M Mannino; Anne G Wheaton; Xingyou Zhang; Wayne H Giles
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

Review 10.  Pulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapy.

Authors:  Jean-Louis Corhay; Delphine Nguyen Dang; Hélène Van Cauwenberge; Renaud Louis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-12-16
View more
  3 in total

Review 1.  Current views in chronic obstructive pulmonary disease pathogenesis and management.

Authors:  Ahmed J Alfahad; Mai M Alzaydi; Ahmad M Aldossary; Abdullah A Alshehri; Fahad A Almughem; Nada M Zaidan; Essam A Tawfik
Journal:  Saudi Pharm J       Date:  2021-10-29       Impact factor: 4.330

2.  Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Thu-Minh Nguyen; Thu-Hue Ngo; Anh-Quan Truong; Dinh-Hoa Vu; Dinh-Chi Le; Ngan-Binh Vu; Tuyet-Nga Can; Hoang-Anh Nguyen; Thu-Phuong Phan; Françoise Van Bambeke; Céline Vidaillac; Quy-Chau Ngo
Journal:  Pharmaceutics       Date:  2021-03-27       Impact factor: 6.321

Review 3.  Current Overview on Therapeutic Potential of Vitamin D in Inflammatory Lung Diseases.

Authors:  Muhammad Afzal; Imran Kazmi; Fahad A Al-Abbasi; Sultan Alshehri; Mohammed M Ghoneim; Syed Sarim Imam; Muhammad Shahid Nadeem; Maryam Hassan Al-Zahrani; Sami I Alzarea; Ali Alquraini
Journal:  Biomedicines       Date:  2021-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.